One of the most striking and diagnostically informative skin conditions associated with venous disease is venous eczema — also known as stasis dermatitis or gravitational eczema. This inflammatory skin condition, which develops specifically in areas of the lower leg subjected to chronic venous hypertension, is frequently misdiagnosed as a primary skin condition and treated with topical preparations that address the surface manifestations without touching the underlying venous cause. Understanding its vascular origins is essential for its effective management.
Venous eczema develops as a consequence of the same chronic tissue inflammation that drives all of the advanced skin changes of venous disease. The elevated capillary pressure of venous hypertension creates leaky capillaries that allow plasma proteins — and eventually red blood cells — to escape into the surrounding tissue. These extravasated proteins and breakdown products of red blood cells trigger a chronic inflammatory response in the skin and subcutaneous tissue that manifests as the typical features of eczema — redness, itching, scaling, weeping, and crusting.
The distribution of venous eczema follows the distribution of venous hypertension in the lower leg — typically most prominent around the ankle and medial lower leg, often bilateral but asymmetric, and typically worse in areas where varicose veins are most prominent. This distribution pattern distinguishes it from other forms of eczema, which do not have this characteristic gravitational and vascular distribution. The skin affected by venous eczema is also characteristically itchy, leading to scratching that damages the already-fragile skin and increases the risk of wound formation.
Topical treatment of venous eczema — with emollients to reduce scaling and occasionally with mild topical corticosteroids to reduce the acute inflammatory flare — provides symptomatic relief but does not address the underlying venous hypertension that is driving the inflammatory process. Without concurrent treatment of the venous disease, the eczema will recur repeatedly and progressively worsen. This explains the pattern seen in many patients referred to dermatology with treatment-resistant lower leg eczema — the skin condition appears to resist topical treatment because the treatment being applied does not address the venous cause that is perpetuating the inflammation.
Vascular specialists and dermatologists increasingly collaborate in the management of venous eczema, ensuring that patients receive both the dermatological treatment needed for symptomatic control and the vascular treatment needed to address the underlying cause. Studies have demonstrated that venous ablation procedures — correcting the reflux that drives venous hypertension — produce significant improvement in venous eczema independently of topical treatment. Patients who have been managing chronic lower leg eczema with dermatological treatments without obtaining lasting control should request venous assessment as a potential underlying cause.
